Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

THL halts trading on 'materially lower' earnings expectations
Markets

THL halts trading on 'materially lower' earnings expectations

In February THL's net profit guidance for FY2024 was $75m.

BNZ's 1H profit and margins ease
Markets

BNZ's 1H profit and margins ease

Net profit was down 5.3% on the previous year's first half. 

NZ sharemarket falls due to global inflation fears
Markets Market close

NZ sharemarket falls due to global inflation fears

The S&P/NZX 50 Index closed at 11,867.58, down 89.92 points or 0.75%.

Graham Skellern 01 May 2024
Michael Hill buffs up security as robbery costs climb
Retail

Michael Hill buffs up security as robbery costs climb

The jeweller has invested in new smash-proof assault glass and fog cannons.

Gregor Thompson 01 May 2024